My impression is that the oncology community has jumped on this category of drugs in lieu of tamoxifen in a huge number of people much too quickly. When aromatase inhibitors first came out and were tested, it was stage 3 and 4 women. Survival was clearly better than with tamoxifen. Now they're giving it to all these women with stage 1 and stage 0 cancer, who are likely to be cured, and they have no long-term data.
Quotes about tamoxifen (2 Quotes)
The use of tamoxifen can prevent breast cancer in patients who have no evidence of breast cancer but are at high risk of getting it.